{"id":"W2121469814","doi":"10.1186/1710-1492-7-9","title":"Long-term benefits of omalizumab in a patient with severe non-allergic asthma","year":2011,"lang":"en","type":"article","venue":"Allergy Asthma and Clinical Immunology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Omalizumab; Medicine; Exacerbation; Asthma; Immunoglobulin E; Quality of life (healthcare); Allergic asthma; Comorbidity; Intensive care medicine; Asthma exacerbations; Immunology; Pediatrics; Internal medicine; Antibody","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001389618,0.0002697388,0.0007582229,0.0001508907,0.00005122403,0.000004862585,0.0001487101,0.000363417,0.0005001319],"category_scores_gemma":[0.00006449885,0.0001969668,0.0001747656,0.0001871134,0.0005905329,0.00008333435,0.0001540244,0.0003875567,0.00002953375],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001938819,"about_ca_system_score_gemma":0.0001686323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000102319,"about_ca_topic_score_gemma":0.0004568421,"domain_scores_codex":[0.997925,0.0001471094,0.0008580618,0.0004974081,0.0001747061,0.0003976887],"domain_scores_gemma":[0.9988187,0.0001255866,0.0002671737,0.0004496919,0.000135565,0.0002032942],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01223816,0.004456246,0.6521497,0.0001071014,0.001283812,0.002096038,0.001157435,0.00001085786,0.0001645237,0.000857474,0.0000833708,0.3253953],"study_design_scores_gemma":[0.005416606,0.00843616,0.9832438,0.0003123925,0.00003142505,0.000664288,0.0003321858,0.00001488444,0.0001788587,0.00002885133,0.001111524,0.0002290869],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928968,0.003404156,0.00002178096,0.00009772403,0.0001589104,0.0002962044,0.000006669003,0.00002918753,0.00308859],"genre_scores_gemma":[0.9978265,0.001267997,0.0002511926,0.0003425589,0.00005562144,0.00002664289,0.00001865789,0.00003164734,0.000179248],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3310941,"threshold_uncertainty_score":0.8032074,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02209657889995572,"score_gpt":0.2783935389574983,"score_spread":0.2562969600575426,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}